Skip to main content

Table 2 Odds ratio (95% CI) for acute kidney injury in intensive care unit hospitalization in Korea, 2008 to 2015

From: Changes in acute kidney injury epidemiology in critically ill patients: a population-based cohort study in Korea

  Crude odds ratio (95% CI) p valuea Adjusted odds ratio (95% CI) p valuea
Age (continuous) 1.02 (1.02–1.02) < .001 1.01 (1.01–1.01) < .001
Gender, male 1.09 (1.08–1.10) < .001 1.02 (1.02–1.03) < .001
Tertiary hospital 0.94 (0.91–0.97) < .001 1.05 (1.05–1.06) 0.365
Year 1.02 (1.02–1.02) < .001 1.18 (1.17–1.20) < .001
Charlson index 1.08 (1.08–1.09) < .001 0.98 (0.95–1.02) < .001
Comorbidity
 Myocardial infarction 1.00 (0.97–1.02) 0.857 0.85 (0.83–0.87) < .001
 Congestive heart failure 1.50 (1.48–1.53) < .001 1.16 (1.14–1.18) < .001
 Peripheral vascular disease 1.12 (1.15–1.18) < .001 0.94 (0.93–0.96) < .001
 Cerebrovascular disease 0.97 (0.95–0.98) < .001 0.78 (0.77–0.79) < .001
 Rheumatologic disease 1.23 (1.20–1.26) < .001 0.98 (0.96–1.01) 0.239
 Peptic ulcer disease 1.07 (1.06–1.08) < .001 0.88 (0.87–0.89) < .001
 Liver disease 1.28 (1.27–1.30) < .001 0.99 (0.98–1.01) 0.431
 Diabetes mellitus 1.61 (1.60–1.63) < .001 1.26 (1.25–1.28) < .001
 Renal disease 4.23 (4.15–4.32) < .001 3.45 (3.37–3.52) < .001
 Cancer 1.06 (1.05–1.08) < .001 0.72 (0.70–0.74) < .001
 AIDS/HIV 1.46 (1.18–1.81) < .001 0.85 (0.67–1.06) 0.151
Organ dysfunction
 Respiratory 4.84 (4.75–4.94) < .001 2.97 (2.91–3.04) < .001
 Cardiovascular 5.89 (5.81–5.97) < .001 4.24 (4.18–4.31) < .001
 Hepatic 4.56 (4.33–4.81) < .001 3.46 (3.26–3.67) < .001
 Hematologic 5.24 (5.15–5.33) < .001 3.64 (3.57–3.70) < .001
 Neurologic 2.49 (2.42–2.56) < .001 1.84 (1.78–1.90) < .001
  1. Adjusted for age, gender, tertiary hospital, year, Charlson index, myocardial infarction, congestive heart failure, cerebrovascular disease, rheumatologic disease, peptic ulcer disease, liver disease, diabetes, renal disease, cancer, AIDS/HIV, and organ dysfunction (respiratory, cardiovascular, hepatic, hematologic, neurologic)
  2. AIDS acquired immune deficiency syndrome, CI confidence interval, HIV human immunodeficiency virus
  3. aMixed effects logistic regression model